Treatment strategies in intermediate cervical neoplasia: Implications of radical surgery

van Delft,K. W.M.; Mertens,H. J.M.M.

doi:10.3892/ol.2011.289

May-June 2011 Volume 2 Issue 3

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

May-June 2011 Volume 2 Issue 3

Full Size Image

Article

Treatment strategies in intermediate cervical neoplasia: Implications of radical surgery

Authors:
- K. W.M. van Delft
- H. J.M.M. Mertens
View Affiliations / Copyright

Affiliations: Department of Gynecology, Orbis Medical Center, 6162 BG Sittard-Geleen, The Netherlands
Pages: 575-578
|
Published online on: March 21, 2011

https://doi.org/10.3892/ol.2011.289
Expand metrics +

Abstract

Treatment strategies for cervical intraepithelial neoplase (CIN)2 lesions differ among gynaecologists. To evaluate the differences in management of treatment with subsequent implications, all surgical treatment strategies and follow-up methods were retrospectively analysed for patients with intermediate dysplasia of the cervix. This study aimed to evaluate expectant management strategies and the effect of biopsy prior to radical surgery in CIN2. Patients diagnosed with a CIN2 lesion at the Orbis Medical Center in The Netherlands between 2006 and 2007 were retrospectively analysed. The follow-up ended on 1st January 2009. All 141 patients with CIN2 lesions were included; 109 had no previous history of any CIN lesion. Of the 109 patients, 12% (n=13) underwent an immediate radical surgical excision of the transformation zone (LLETZ procedure) and 85% (n=93) underwent a local biopsy. After the lesion was biopsied, expectant management was selected for 59% of the patients. Subsequent smears were normal in 40% of the patients. Of the patients with abnormal smears in follow‑up, the LLETZ procedure was performed in 86% of the patients (n=25). Of these cases, persistent disease was observed in 14% of the patients. After an immediate LLETZ procedure without prior biopsy, follow-up smears were abnormal in 31% of the patients. Persistent disease was significantly lower following radical excision of the lesion with a diagnostic biopsy versus without one (14 versus 31%). After expectant management, the rate of persistent disease was 53% (p<0.001). Overall, the rate of persistent disease was 7%. Due to the high rate of persistent disease and the lower rate of overtreatment, CIN2 lesions should be treated by the excisional procedure. To restrict persistent disease, a biopsy is recommended prior to the actual treatment, since a higher rate of abnormal smears was observed in the follow‑up after immediate radical excisions in the first visit.

View Figures

View References

1	Wright TC, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ and Solomon D: Consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ. American Society for Colposcopy and Cervical Pathology. J Low Genit Tract Disease. 11:223–239. 2007.
2	van Ballegooijen M and Hermens R: Cervical cancer screening in the Netherlands. Eur J Cancer. 36:2244–2246. 2000.
3	De Bruin A, De Koning HJ and Van Ballegooijen M: Gezondheidsenquetes. Cervixuitstrijkjes en mammografieen, Gezondheidsenquêtes 1991 (In Dutch). Maandberichten Gezondheid. 5:4–20. 1993.
4	Werkgroep Oncologische Gynaecologie. Richtlijn cervixcarcinoom. National Guideline The Netherlands 1.2 (In Dutch). 2004
5	Insinga RP, Glass AG and Rush BB: Diagnoses and outcomes in cervical cancer screening: a population-based study. Am J Obstet Gynaecol. 191:105–113. 2004. View Article : Google Scholar : PubMed/NCBI
6	Holschneider CH, Goff B and Barss VA: Cervical intraepithelial neoplasia: Management. Up-to-date version 16.1. January. 2008
7	Spitzer M, Apgar BS and Brotzman GL: Management of histologic abnormalities of the cervix. Am Fam Physician. 73:105–112. 2006.PubMed/NCBI
8	Östör AG: Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynaecol Pathol. 12:186–192. 1993.PubMed/NCBI
9	McCredie MRE, Sharples KJ, Paul C, et al: Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol. 9:425–434. 2008. View Article : Google Scholar : PubMed/NCBI
10	Werkgroep Oncologische Gynaecologie. Richtlijn cervicale intra-epitheliale neoplasie (CIN). National Guideline The Netherlands 1.1 (In Dutch). 2004
11	Kyrgiou M, Koliopoulos G, Martin-Hirsch P, Arbyn M, Prendiville W and Paraskevaidis E: Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis. Lancet. 367:489–498. 2006. View Article : Google Scholar
12	Kyrgiou M, Tsoumpou I, Vrekoussis T, et al: The up-to-date evidence on colposcopy practice and treatment of cervical intraepithelial neoplasia: the Cochrane colposcopy and cervical cytopathology collaborative group (C5 group) approach. Cancer Treat Rev. 32:516–523. 2006. View Article : Google Scholar
13	Dunn TS, Burke M and Shwayder J: A ‘see and treat’ management for high-grade squamous intraepithelial lesion pap smears. J Low Genit Tract Disease. 7:104–106. 2003.
14	Lindeque BG: Management of cervical premalignant lesions. Best Practice & Research Clinical Obstetrics and Gynaecology. 19:545–561. 2005.PubMed/NCBI
15	Kyrgiou M, Koliopoulos G, Martin-Hirsch P, et al: Management of minor cervical cytological abnormalities: A systematic review and a meta-analysis of the literature. Cancer Treat Rev. 33:514–520. 2007. View Article : Google Scholar : PubMed/NCBI
16	Kalliala I, Anttila A, Pukkala E and Nieminen P: Risk of cervical and other cancers after treatment of cervical intraepithelial neoplasia: retrospective cohort study. BMJ. 331:1183–1185. 2005. View Article : Google Scholar

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

Treatment strategies in intermediate cervical neoplasia: Implications of radical surgery

This article is mentioned in:

Abstract

Figure 1

Related Articles